Assura PLC Reduction of RCF (8332G)

TIDMAGR

RNS Number : 8332G

Assura PLC

29 July 2021

29 July 2021

Assura plc

Reduction of Revolving Credit Facility ("RCF")

Assura plc ("Assura"), the leading primary care property investor and developer, today announces that it has given notice under its Revolving Credit Facility ("RCF") agreement to voluntarily cancel GBP100 million of the existing GBP225 million facility which runs to November 2024.

Following the cancellation, the RCF will stand at GBP125 million and is currently undrawn.

Jayne Cottam, Chief Financial Officer, commented:

"Our recent successful Sustainability and Social Bond issuances have demonstrated the range of debt markets that Assura can now access, reflecting the strength of our business model, our balance sheet and our A- rating from Fitch.

"We have therefore taken the opportunity to further reduce our revolving credit facility to GBP125 million in order to improve the efficiency of our funding profile.

"We are grateful to the banks and all our lenders for their continuing, flexible support."

- Ends -

For more information, please contact:

 
  Assura plc                        Tel: [phone] 
   Jayne Cottam, CFO                 E mail: [e-mail] 
   David Purcell, Head of Investor 
   Relations 
  Finsbury                          Tel: [phone] 
   Gordon Simpson                    Email: [e-mail] 
   James Thompson 
 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2021, Assura's property portfolio was valued at GBP2,453 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IODDGGDRBSDDGBI

(END) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)